Prevalence and Clinical Implications of Autoantibodies in Juvenile Dermatomyositis: A Single-Center Experience From India.
Alen Joe JosephBaehat DhakalSathvik Reddy ErlaYogendra SinghLata SinghAshish D UpadhyayNarendra Kumar BagriRakesh LodhaS K KabraPublished in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2024)
MSAs/MAAs were identified in 81% of children with JDM in our study, which is higher than most other studies. The most frequently observed antibodies displayed a pattern consistent with other studies. Anti-TIF1γ was associated with a younger age at onset and disease flares even after attaining a complete clinical response. Anti-NXP2 had higher odds of severe muscular weakness. These observations suggest consistency in certain phenotypic associations observed across geographic boundaries.